Smith Group Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-22,800
| Closed | -$99K | – | 524 |
|
|
2016
Q1 | $99K | Sell |
22,800
-129,670
| -85% | -$563K | ﹤0.01% | 275 |
|
|
2015
Q4 | $935K | Sell |
152,470
-3,590
| -2% | -$22K | 0.03% | 175 |
|
|
2015
Q3 | $893K | Buy |
+156,060
| New | +$893K | 0.03% | 169 |
|
|
2013
Q4 | – | Sell |
-183,820
| Closed | -$923K | – | 449 |
|
|
2013
Q3 | $923K | Sell |
183,820
-19,000
| -9% | -$95.4K | 0.04% | 181 |
|
|
2013
Q2 | $905K | Buy |
+202,820
| New | +$905K | 0.04% | 185 |
|